Cipla's South African arm completes acquisition of Mirren Ltd
New Delhi: Drug major Cipla has recently stated that its South African subsidiary has completed the acquisition of pharma firm Mirren (Pty) Ltd. Cipla Medpro South Africa (Pty) Ltd has completed the acquisition of 100 per cent stake in South African firm Mirren on October 22, 2018, Cipla said in a filing to BSE.
In July, the company informed that Cipla Medpro had signed an agreement to fully acquire Mirren for a cash consideration of South African Rand 450 million to be paid on closing of the transaction.
Cipla Medpro is a wholly-owned subsidiary of Mumbai-based Cipla Ltd.
Shares of Cipla were trading at Rs 620.90 per scrip on BSE, down 1.32 per cent from the previous close.
Read Also: Cipla received USFDA approval for Albendazole
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd